ART Compass

What ART Compass does

ART Compass, founded in 2018 by Dr. Carol Lynn Curchoe, is a privately held software company headquartered in Orange County, California, that builds a mobile-first Laboratory Information Management System (LIMS) for in vitro fertilization (IVF) clinics and embryology laboratories. The platform combines a quality management system (QMS), patient portal, and compliance-tracking tools into a single product distributed through native iOS and Android applications and a web-based portal, targeting the regulatory and operational workflows of IVF labs under CLIA, CAP, HIPAA, and WHO standards.

The platform's core capabilities include digital personnel and training files, competency assessments built on 80+ validated modules (sourced in part through a 2020 partnership with the World Health Organization for high-definition andrology imagery), document and SOP control with e-signatures, inventory and cryostorage management, audit-ready reporting, and an AI-powered embryo selection module that uses computer vision on embryo images and developmental patterns. ART Compass monetizes through a SaaS subscription model, pricing is not publicly disclosed, and go-to-market relies on direct enterprise sales supplemented by presence at ASRM industry conferences, content marketing, and a multi-channel social footprint.

The company operates without disclosed external funding and was founded as a lean team of 1-10 employees. Its primary customers are IVF clinics, embryologists, and lab directors, with downstream demand from IVF patients via the HIPAA-compliant patient portal. ART Horizons, a fertility-focused fitness and wellness sub-brand with a Newport Beach training facility and companion app, extends ART Compass into the patient-services vertical, signaling an intent to grow beyond pure lab software into adjacent fertility care offerings.

Name

ART Compass

Legal name

Art Compass

Website

https://artcompass.io

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

ART Compass, founded in 2018 and headquartered in Orange County, California, provides a mobile-first IVF laboratory information management system (LIMS) and quality management platform to IVF clinics and embryologists, automating CLIA, CAP, HIPAA, and WHO compliance, competency assessments, and audit-ready reporting.

Ownership category

akta.pro rank

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. SaaS Platform Subscription: Mobile application and web-based portal subscription for IVF laboratories. The platform serves as a LIMS, patient portal, and quality management system. Available on iOS, Android, and via Chrome browser web portal.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

ART Compass provides a mobile-first IVF Laboratory Information Management System (LIMS) that combines a quality management system (QMS), patient portal, and compliance tracking for IVF clinics and embryology laboratories. The platform centralizes embryo tracking, cryostorage management, personnel files, training records, SOPs, and CLIA/CAP compliance documentation. It is delivered via iOS/Android apps and a web-based portal, and includes AI-powered embryo assessment decision support and over 80 validated competency assessment modules.

Product overview

ART Compass is a unified platform consisting of a core mobile-first IVF Laboratory Information Management System (LIMS) with integrated patient portal and quality management system, complemented by the ART Horizons wellness sub-brand. The platform encompasses the ART Compass mobile app for iOS/Android, cloud-based quality management tools including competency assessments (over 80 modules for sperm and embryo morphology), the IVF Lab Digital Playbook for monthly quality audits, AI-powered embryo selection decision support, and compliance management for CLIA, CAP, HIPAA, and WHO standards.

Differentiator

Problem solved

Functional benefit

Brands

• ART Horizons: A fitness fertility program combining expert fertility-focused coaching, personal strength training, and a wellness app. Located in Newport Beach facility or virtual. Part of ART Compass offerings for holistic fertility support.

Products and services

• ART Compass Platform

Quantifiable outcome

• Defeats CAP's number one most cited deficiency - staff-related checklist items
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature9 records

Partnerships

One partnership is on record.

• World Health Organization (WHO)coreStrategic or Co-development Partner · 12 January 2020ART Compass partnered with the World Health Organization to deliver educational content for Andrology competency assessments using high definition images from the planned 6th Edition Laboratory manual for the examination and processing of human semen. This partnership provides standardized educational content from the world's foremost authority on semen analysis methodology.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• LabWare: Established general-purpose LIMS vendor serving regulated laboratories including clinical and life science labs. Represents the broader LIMS category that ART Compass must displace or integrate with in IVF accounts.
• STARLIMS (Abbott): Mature LIMS platform sold to clinical and analytical labs, including those with regulatory workflows. Competes for the same lab-IT budget that ART Compass targets in IVF settings, but without IVF-specific features.
• LabVantage Solutions: Enterprise LIMS provider used across regulated lab environments. Comparable as a horizontal LIMS incumbent that hospital systems may prefer for standardized lab IT, putting pricing pressure on vertical players like ART Compass.
• CooperSurgical (Wallace, ORIGIO): Large fertility solutions provider with a broad ART portfolio of consumables, devices, and software. Comparable as a one-stop vendor for IVF clinics that competes for IT/software wallet share alongside lab supplies.
• Vitrolife: Global IVF media, devices, and lab software supplier offering lab management and time-lapse systems. Operates broadly in ART, overlapping with ART Compass on lab tracking and workflow digitalization.

Emerging players

• TMRW Life Sciences: Digital cryostorage and embryo management platform for IVF clinics. Directly competes with ART Compass's cryostorage inventory and tracking capabilities with a focus on automated storage hardware plus software.
• AiVF: AI-driven IVF platform (EMA) explicitly integrated with ART Compass for embryo assessment, applying computer vision to embryo selection. Targets the same IVF clinic market with a more focused AI workflow rather than a full LIMS/QMS.
• Future Fertility: AI-driven embryo and oocyte assessment tool for IVF clinics. Overlaps with ART Compass's AI embryo selection roadmap, illustrating the category of specialized AI add-ons that could complement or compete with its module.

Direct peers

• Genea Biomedx: Provides IVF lab technology (Gems, Geri, Gidget) including lab workflow and time-lapse embryo monitoring, overlapping with ART Compass's embryology lab management and quality control positioning.
• EmbryoDirector: IVF-focused laboratory information and workflow management software exhibited alongside ART Compass at ASRM 2019, serving the same embryology lab buyer with a comparable clinic-management platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• YouTubeyoutube.com/@FertilityGuidanceTechnologies
• Facebookfacebook.com/Fertilityguidancetechnologies
• LinkedInlinkedin.com/company/art-compass
• Instagraminstagram.com/fertilitytechs
• Xx.com/ARTCompassApp

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ART Compass